Christopher G. Smith

5.4k total citations
33 papers, 968 citations indexed

About

Christopher G. Smith is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher G. Smith has authored 33 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher G. Smith's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Pain Mechanisms and Treatments (4 papers). Christopher G. Smith is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Pain Mechanisms and Treatments (4 papers). Christopher G. Smith collaborates with scholars based in United Kingdom, United States and Netherlands. Christopher G. Smith's co-authors include Nitzan Rosenfeld, Dineika Chandrananda, Florent Moulière, Francesco Marass, Kevin J. Whitehead, James Morris, Sergio A. Jiménez, Clinton T. Baldwin, Anthony M. Reginato and Darwin J. Prockop and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Christopher G. Smith

33 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher G. Smith United Kingdom 17 422 355 336 237 125 33 968
Mélissa Taylor France 18 340 0.8× 317 0.9× 370 1.1× 275 1.2× 69 0.6× 42 954
Rachel Bikoff United States 5 334 0.8× 865 2.4× 247 0.7× 315 1.3× 69 0.6× 7 1.3k
Harry Harvey Ireland 14 342 0.8× 448 1.3× 423 1.3× 152 0.6× 76 0.6× 23 1.1k
Kevin McDonnell United States 16 499 1.2× 961 2.7× 497 1.5× 220 0.9× 95 0.8× 39 1.5k
Chad A. Ellis United States 14 228 0.5× 876 2.5× 462 1.4× 151 0.6× 113 0.9× 14 1.7k
Justin Bottsford-Miller United States 16 324 0.8× 559 1.6× 591 1.8× 163 0.7× 67 0.5× 42 1.4k
Peter Sidaway United States 13 191 0.5× 404 1.1× 435 1.3× 192 0.8× 74 0.6× 267 1.1k
Patricia M.M.B. Soetekouw Netherlands 20 348 0.8× 782 2.2× 378 1.1× 424 1.8× 87 0.7× 46 1.3k
Nives Pećina‐Šlaus Croatia 18 261 0.6× 810 2.3× 298 0.9× 149 0.6× 147 1.2× 56 1.4k
Satoshi Kiyama Japan 16 329 0.8× 599 1.7× 324 1.0× 199 0.8× 118 0.9× 36 1.0k

Countries citing papers authored by Christopher G. Smith

Since Specialization
Citations

This map shows the geographic impact of Christopher G. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Smith more than expected).

Fields of papers citing papers by Christopher G. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher G. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Smith. The network helps show where Christopher G. Smith may publish in the future.

Co-authorship network of co-authors of Christopher G. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Smith. A scholar is included among the top collaborators of Christopher G. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Smith. Christopher G. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Christopher G., Koen J. Hartemink, Robert C. Rintoul, et al.. (2025). Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. PLoS Medicine. 22(4). e1004574–e1004574. 2 indexed citations
2.
Spiliopoulou, Pavlina, Stephen B. Strum, Alexandra Easson, et al.. (2024). 226TiP CLEAR-Me: Interception trial to detect and clear molecular residual disease in patients with high-risk melanoma. Annals of Oncology. 35. S306–S306. 1 indexed citations
3.
Zou, Jinfeng, Lisa Avery, Anna Spreafico, et al.. (2023). Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).. Journal of Clinical Oncology. 41(16_suppl). 6065–6065. 1 indexed citations
4.
Rossi, Sabrina H., Kevin Brennan, Gahee Park, et al.. (2022). Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework. Science Advances. 8(39). eabn9828–eabn9828. 7 indexed citations
5.
Markus, Havell, Dineika Chandrananda, Elizabeth Moore, et al.. (2022). Refined characterization of circulating tumor DNA through biological feature integration. Scientific Reports. 12(1). 1928–1928. 33 indexed citations
6.
Hudecova, Irena, Christopher G. Smith, Robert Hänsel‐Hertsch, et al.. (2021). Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA. Genome Research. 32(2). 215–227. 58 indexed citations
7.
Heider, Katrin, Jonathan C. M. Wan, James Hall, et al.. (2020). Detection of ctDNA from Dried Blood Spots after DNA Size Selection. Clinical Chemistry. 66(5). 697–705. 36 indexed citations
8.
Souza, Bárbara Kunzler, André T. Brunetto, Caroline Brunetto de Farias, et al.. (2020). Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma. Molecular Biology Reports. 47(9). 6817–6828. 6 indexed citations
9.
Smith, Christopher G., et al.. (2020). Hepatic Angiosarcoma: A Case Presentation. Cureus. 12(2). e6848–e6848. 3 indexed citations
10.
Mair, Richard, Florent Moulière, Christopher G. Smith, et al.. (2018). Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models. Cancer Research. 79(1). 220–230. 68 indexed citations
11.
Moulière, Florent, Richard Mair, Dineika Chandrananda, et al.. (2018). Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO Molecular Medicine. 10(12). 117 indexed citations
12.
Patel, Keval, Kristan E. van der Vos, Christopher G. Smith, et al.. (2017). Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer. Scientific Reports. 7(1). 5554–5554. 84 indexed citations
13.
Ring, Howard, Roxanne Hook, Christopher G. Smith, et al.. (2016). Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: study protocol for a cluster randomised controlled trial. Trials. 17(1). 297–297. 6 indexed citations
14.
Smith, Christopher G., David J. Fisher, Bart Claes, et al.. (2013). Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy ± Cetuximab. Clinical Cancer Research. 19(15). 4104–4113. 86 indexed citations
15.
Morrow, Christopher J., Mohammad A. Ghattas, Christopher G. Smith, et al.. (2010). Src Family Kinase Inhibitor Saracatinib (AZD0530) Impairs Oxaliplatin Uptake in Colorectal Cancer Cells and Blocks Organic Cation Transporters. Cancer Research. 70(14). 5931–5941. 24 indexed citations
16.
Smith, Christopher G., Bart Claes, David I. Fisher, et al.. (2010). High throughput somatic profiling of the Ras-Raf-MAP and PI3K-PTEN-Akt pathways in advanced colorectal cancer and correlations with response to cetuximab. Annals of Oncology. 21. 191–191. 1 indexed citations
17.
Whitehead, Kevin J., Christopher G. Smith, John Curnow, et al.. (2009). Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. Brain Behavior and Immunity. 24(4). 569–576. 59 indexed citations
18.
Hiscox, Stephen, Nicola Jordan, Christopher G. Smith, et al.. (2008). Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Research and Treatment. 115(1). 57–67. 59 indexed citations
19.
Smith, Christopher G., Norman G. Bowery, & Kevin J. Whitehead. (2007). GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms. Neuropharmacology. 53(8). 975–981. 22 indexed citations
20.
Devall, Adam, et al.. (2006). Monolithic column-based reversed-phase liquid chromatography separation for amino acid assay in microdialysates and cerebral spinal fluid. Journal of Chromatography B. 848(2). 323–328. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026